LJI308

Modify Date: 2024-01-18 19:02:22

LJI308 Structure
LJI308 structure
Common Name LJI308
CAS Number 1627709-94-7 Molecular Weight 368.377
Density 1.3±0.1 g/cm3 Boiling Point 486.6±45.0 °C at 760 mmHg
Molecular Formula C21H18F2N2O2 Melting Point N/A
MSDS N/A Flash Point 248.1±28.7 °C

 Use of LJI308


LJI308 is a new and potent pan-RSK inhibitor, with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.IC50 value: 6/4/13 nMTarget: RSK1/2/3in vitro: LJI308 efficiently inhibits RSK activity. LJI308 inhibites S6K1 with an IC50 of 0.8 μM, representing a 200-fold lower inhibition than that of RSK2. LJI308 inhibits MEK4 less than 50% at 10 μMand HIP kinase 1 less than 50% at 1 μM. [1] LJI308 inhibits the growth and survival of TNBC. LJI308 also suppresses the growth of HTRY-LT cells in 3-dimensional soft agar cultures. LJI308 is one of the first potent and effective targeted therapies for TNBC that, unlike currently utilized drugs, exhibits efficacy in eliminating the CSC population. [2]

 Names

Name 2,6-Difluoro-4-{4-[4-(4-morpholinyl)phenyl]-3-pyridinyl}phenol
Synonym More Synonyms

 LJI308 Biological Activity

Description LJI308 is a new and potent pan-RSK inhibitor, with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.IC50 value: 6/4/13 nMTarget: RSK1/2/3in vitro: LJI308 efficiently inhibits RSK activity. LJI308 inhibites S6K1 with an IC50 of 0.8 μM, representing a 200-fold lower inhibition than that of RSK2. LJI308 inhibits MEK4 less than 50% at 10 μMand HIP kinase 1 less than 50% at 1 μM. [1] LJI308 inhibits the growth and survival of TNBC. LJI308 also suppresses the growth of HTRY-LT cells in 3-dimensional soft agar cultures. LJI308 is one of the first potent and effective targeted therapies for TNBC that, unlike currently utilized drugs, exhibits efficacy in eliminating the CSC population. [2]
Related Catalog
References

[1]. Aronchik I, et al. Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers. Mol Cancer Res. 2014 May;12(5):803-12.

[2]. Davies AH, et al. Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells. Oncotarget. 2015 Aug 21;6(24):20570-7.

[3]. Jain R, et al. Discovery of Potent and Selective RSK Inhibitors as Biological Probes. J Med Chem. 2015 Sep 10;58(17):6766-83.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 486.6±45.0 °C at 760 mmHg
Molecular Formula C21H18F2N2O2
Molecular Weight 368.377
Flash Point 248.1±28.7 °C
Exact Mass 368.133636
LogP 2.87
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.602
Storage condition -20℃

 Synonyms

2,6-Difluoro-4-{4-[4-(4-morpholinyl)phenyl]-3-pyridinyl}phenol
Phenol, 2,6-difluoro-4-[4-[4-(4-morpholinyl)phenyl]-3-pyridinyl]-
LJI308
LJI-308
Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: LJI-308
  • Price: $450.0/100mg $800.0/250mg $1600.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

Get all suppliers and price by the below link:

LJI308 suppliers


Price: $198/10mM*1mLinDMSO

Reference only. check more LJI308 price

Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3